Understanding the nature of mammary NIS expression would not only be useful in breast cancer research but may potentially benefit understanding of other extrathyroidal malignant tissues expressing NIS, including ovary, lung, colon, and endometrium [6]. Here, SLC5A5 is linked to breast carcinoma.